KKR & Co. Inc. (NYSE:KKR – Free Report) had its price objective increased by The Goldman Sachs Group from $65.00 to $72.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the asset manager’s stock.
A number of other equities analysts have also weighed in on KKR. Oppenheimer increased their price target on KKR & Co. Inc. from $80.00 to $81.00 and gave the company an outperform rating in a research report on Thursday, April 13th. Morgan Stanley increased their price target on KKR & Co. Inc. from $54.00 to $59.00 and gave the company an equal weight rating in a research report on Tuesday, July 18th. StockNews.com assumed coverage on KKR & Co. Inc. in a research report on Thursday, May 18th. They set a sell rating for the company. Citigroup raised their price objective on KKR & Co. Inc. from $69.00 to $75.00 in a research report on Tuesday. Finally, Keefe, Bruyette & Woods raised their price objective on KKR & Co. Inc. from $71.00 to $76.00 and gave the stock an outperform rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, KKR & Co. Inc. currently has a consensus rating of Moderate Buy and an average target price of $71.04.
View Our Latest Research Report on KKR
KKR & Co. Inc. Trading Down 0.7 %
KKR & Co. Inc. (NYSE:KKR – Get Free Report) last released its quarterly earnings results on Monday, August 7th. The asset manager reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.23. KKR & Co. Inc. had a return on equity of 4.50% and a net margin of 11.02%. The business had revenue of $3.63 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the company posted $0.64 EPS. KKR & Co. Inc.’s revenue for the quarter was up 1021.4% on a year-over-year basis. On average, sell-side analysts expect that KKR & Co. Inc. will post 2.76 earnings per share for the current fiscal year.
KKR & Co. Inc. Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Thursday, August 17th will be paid a dividend of $0.165 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Wednesday, August 16th. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 51.56%.
Insider Transactions at KKR & Co. Inc.
In other news, major shareholder Phorm Investors L.P. Kkr purchased 1,735,988 shares of the business’s stock in a transaction dated Friday, July 21st. The stock was bought at an average cost of $3.30 per share, with a total value of $5,728,760.40. Following the purchase, the insider now directly owns 24,411,968 shares of the company’s stock, valued at $80,559,494.40. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, major shareholder Kkr Group Partnership L.P. sold 15,952,381 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $21.00, for a total value of $335,000,001.00. Following the sale, the insider now owns 44,782,619 shares of the company’s stock, valued at approximately $940,434,999. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Phorm Investors L.P. Kkr acquired 1,735,988 shares of the business’s stock in a transaction on Friday, July 21st. The stock was acquired at an average price of $3.30 per share, with a total value of $5,728,760.40. Following the transaction, the insider now owns 24,411,968 shares in the company, valued at approximately $80,559,494.40. The disclosure for this purchase can be found here. Insiders bought 2,222,651 shares of company stock valued at $19,300,198 in the last three months. Corporate insiders own 39.34% of the company’s stock.
Institutional Investors Weigh In On KKR & Co. Inc.
A number of institutional investors and hedge funds have recently made changes to their positions in the company. Massmutual Trust Co. FSB ADV grew its holdings in shares of KKR & Co. Inc. by 63.7% during the first quarter. Massmutual Trust Co. FSB ADV now owns 514 shares of the asset manager’s stock worth $27,000 after buying an additional 200 shares in the last quarter. Disciplined Investments LLC increased its stake in shares of KKR & Co. Inc. by 2,861.1% in the 1st quarter. Disciplined Investments LLC now owns 533 shares of the asset manager’s stock valued at $28,000 after purchasing an additional 515 shares during the last quarter. Quadrant Capital Group LLC increased its stake in shares of KKR & Co. Inc. by 285.9% in the 4th quarter. Quadrant Capital Group LLC now owns 714 shares of the asset manager’s stock valued at $33,000 after purchasing an additional 529 shares during the last quarter. Webster Bank N. A. increased its stake in shares of KKR & Co. Inc. by 329.5% in the 1st quarter. Webster Bank N. A. now owns 859 shares of the asset manager’s stock valued at $45,000 after purchasing an additional 659 shares during the last quarter. Finally, Delta Asset Management LLC TN bought a new stake in KKR & Co. Inc. during the 4th quarter worth $46,000. Institutional investors own 54.79% of the company’s stock.
KKR & Co. Inc. Company Profile
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- The How And Why of Investing in Oil Stocks
- Investing in Coffee: 3 Great Strategies to Consider
- Best Stocks Under $5.00
- 5 Best Stocks to Buy in a Bear Market
- What is the Death Cross and How Can Investors Use it For Successful Trading?
- 3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
